Research Scientist / Post-Doctoral researcher
- Employer
- Georgia State University
- Location
- Atlanta, Georgia
- Salary
- Salary will be negotiable, depending on the experiences of candidates
- Closing date
- Aug 24, 2021
View more
- Discipline
- Life Sciences, Immunology, Molecular Biology, Virology
- Position Type
- Full Time
- Job Type
- Postdoc, Postdoc Fellowship, Research Scientist, Staff Scientist
- Organization Type
- Academia
NIH-funded Research Scientist / Post-Doctoral position is available. Salary will be in a range ($50,000 - $70,000 /year) plus health insurance and retirement fringe benefits, depending on the experiences of candidates.
Job Summary: Molecular biology, mRNA vaccines, virology, immunology. Universal influenza vaccines, cross protective SARS-CoV-2 vaccines, RSV animal models.
Strong molecular biology and mRNA vaccines, virology, and immunology. Research projects include development of universal influenza vaccines, cross protective SARS-CoV-2 vaccines, human respiratory syncytial Virus (RSV) vaccines. Research experiences in mRNA vaccines, mouse and ferret animal models are highly preferred.
Qualifications: Candidates should have a Ph.D., M.D., or equivalent degree, and expertise in molecular biology and Virology. Preferred candidates are expected to have research experiences in the fields of viral immunology, mRNA vaccines, flow cytometry, mouse and ferret animal models. US citizenship or permanent resident status of applicant is preferable
Interested candidates should send an application packet, including all of the following as a single PDF file by email to Dr. Sang-Moo Kang (skang24@gsu.edu).
- Cover letter indicating current projects and future research interests (<1 page);
- Curriculum vitae;
- Brief summary of previous research experience (1-3 pages);
- Names and contact information for 3 references.
- The laboratory of Professor Sang-Moo Kang at Georgia State University has NIH-funded Research focusing on the development of universal influenza vaccines, cross protective SARS-CoV-2 vaccines, human respiratory syncytia Virus (RSV) vaccines, using mouse and ferret animal models. The vaccine platforms include mRNA vaccine technology and recombinant protein vaccines. Current lab members are research scientists, assistant professors, and PhD students
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert